Hangping Yao

17PUBLICATIONS
38CO-AUTHORS
Molecular targetsMedical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)VirologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 04, 2026
Pharmaceutical Potential of Antibody-Drug Conjugate Doublets for Targeted Treatment of Cancers Heterogeneously Expressing RON Receptor Tyrosine Kinase.

|May 13, 2026
Inorganic Antibody-Mimetic H-Zeolite Blocks Airborne Viruses via E340-Targeted Biorecognition.

|Apr 11, 2026
Cryo-ET of IgG bivalent binding on SARS-CoV-2 provides structural basis for antibody avidity.

Hangping Yao, Yutong Song, Qi Huang

|Jul 24, 2025
Gut microbiota-associated non-cholesterol sterol dysregulation modulates immune reconstitution during antiretroviral therapy in people living with HIV.

Jingying Pan, Xuebin Tian, Kai Wu

|Jan 21, 2025
Humanized dual-targeting antibody-drug conjugates specific to MET and RON receptors as a pharmaceutical strategy for the treatment of cancers exhibiting phenotypic heterogeneity.

Minghai Wang, Qi Ma, Sreedhar Reddy Suthe

|May 14, 2024
Phase separation-competent FBL promotes early pre-rRNA processing and translation in acute myeloid leukaemia.

Lin Yang, Zhaoru Zhang, Penglei Jiang

Pageof 3

Frequent Collaborators

2 joint publications

Minghai Wang

2 joint publications

Sai Li

2 joint publications

Yutong Song

2 joint publications

Pengxu Qian